Publications

Krauthammer A, Tzivinikos C, Assa A, Miele E, Strisciuglio C, Urlep D, Serban ED, Singh A, Winter HS, Russell RK, Hojsak I, Malham M, Navas-López VM, Croft NM, Lee HM, Ledder O, Shamasneh I, Hussey S, Huynh HQ, Wine E, Shah N, Sladek M, de Meij TG, Romano C, Dipasquale V, Lionetti P, Afzal NA, Aloi M, Lee K, Martín-de-Carpi J, Yerushalmy-Feler A, Subramanian S, Weiss B, Shouval DS. Long-term Outcomes of Paediatric Patients Admitted With Acute Severe Colitis- A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN. Journal of Crohn's & colitis. 2019. PMID: 31120524


Neil Pravin Shah, MD, PhD

Vidula N, Yau C, Wolf D, Rugo HS. Androgen receptor gene expression in primary breast cancer. NPJ breast cancer. 2019. PMID: 31840050


Hope Rugo, MD

Kurzrock R, Bowles DW, Kang H, Meric-Bernstam F, Hainsworth J, Spigel DR, Bose R, Burris H, Sweeney CJ, Beattie MS, Blotner S, Schulze K, Cuchelkar V, Swanton C. Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study. Annals of oncology : official journal of the European Society for Medical Oncology. 2019. PMID: 32067683


Hyunseok Kang, MD, MPH

Blakely CM, Riess JW. Interpretation of ceritinib clinical trial results and future combination therapy strategies for ALK-rearranged NSCLC. Expert review of anticancer therapy. 2019. PMID: 31809604


Collin Blakely, MD, PhD

Olin RL. Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care. Hematology. American Society of Hematology. Education Program. 2019. PMID: 31808886


Rebecca Olin, MD, MSCE

Smith CC. The growing landscape of FLT3 inhibition in AML. Hematology. American Society of Hematology. Education Program. 2019. PMID: 31808872


Catherine Smith, MD

Olin RL. Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care. Blood. 2019. PMID: 31805199


Rebecca Olin, MD, MSCE

Chung A, Liedtke M. Cutaneous plasmablastic plasmacytoma. Blood. 2019. PMID: 31805196


Alfred Chung, MD

Sharma MR, Mehrotra S, Gray E, Wu K, Barry WT, Hudis C, Winer EP, Lyss AP, Toppmeyer DL, Moreno-Aspitia A, Lad TE, Velasco M, Overmoyer B, Rugo HS, Ratain MJ, Gobburu JV. Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance). Journal of clinical pharmacology. 2019. PMID: 31802506


Hope Rugo, MD

Nahas GR, Komanduri KV, Pereira D, Goodman M, Jimenez AM, Beitinjaneh A, Wang TP, Lekakis LJ. Incidence and risk factors associated with a syndrome of persistent cytopenias after CAR-T cell therapy (PCTT). Leukemia & lymphoma. 2019. PMID: 31793821


Krishna Komanduri, MD

Kwon DH, Friedlander T. A TITAN step forward: apalutamide for metastatic castration-sensitive prostate cancer. Annals of translational medicine. 2019. PMID: 32016082


Terence Friedlander, MD

Kwon DH, Friedlander T. A TITAN step forward: apalutamide for metastatic castration-sensitive prostate cancer. Annals of translational medicine. 2019. PMID: 32016082


Daniel Kwon, MD

Whitman J, Kardosh A, Diaz L, Fong L, Hope T, Onodera C, Joseph N, Le D, Fisher G, Bergsland E. Complete Response and Immune-Mediated Adverse Effects With Checkpoint Blockade: Treatment of Mismatch Repair-Deficient Colorectal Neuroendocrine Carcinoma. JCO precision oncology. 2019. PMID: 35100735


Lawrence Fong, MD

Gilligan T, Lin DW, Aggarwal R, Chism D, Cost N, Derweesh IH, Emamekhoo H, Feldman DR, Geynisman DM, Hancock SL, LaGrange C, Levine EG, Longo T, Lowrance W, McGregor B, Monk P, Picus J, Pierorazio P, Rais-Bahrami S, Saylor P, Sircar K, Smith DC, Tzou K, Vaena D, Vaughn D, Yamoah K, Yamzon J, Johnson-Chilla A, Keller J, Pluchino LA. Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2019. PMID: 31805523


Rahul Aggarwal, MD

Savoie MB, Paciorek A, Zhang L, Van Blarigan EL, Sommovilla N, Abrams D, Atreya CE, Bergsland EK, Chern H, Kelley RK, Ko A, Laffan A, Sarin A, Varma MG, Venook AP, Van Loon K. Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation. Journal of gastrointestinal cancer. 2019. PMID: 30058032


Alan Venook, MD

Oglesby A, Algazi AP, Daud AI. Intratumoral and Combination Therapy in Melanoma and Other Skin Cancers. American journal of clinical dermatology. 2019. PMID: 31228012


Alain Algazi, MD

Savoie MB, Paciorek A, Zhang L, Van Blarigan EL, Sommovilla N, Abrams D, Atreya CE, Bergsland EK, Chern H, Kelley RK, Ko A, Laffan A, Sarin A, Varma MG, Venook AP, Van Loon K. Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation. Journal of gastrointestinal cancer. 2019. PMID: 30058032


Robin Kate ("Katie") Kelley, MD

Oglesby A, Algazi AP, Daud AI. Intratumoral and Combination Therapy in Melanoma and Other Skin Cancers. American journal of clinical dermatology. 2019. PMID: 31228012


Adil Daud, MD

Savoie MB, Paciorek A, Zhang L, Van Blarigan EL, Sommovilla N, Abrams D, Atreya CE, Bergsland EK, Chern H, Kelley RK, Ko A, Laffan A, Sarin A, Varma MG, Venook AP, Van Loon K. Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation. Journal of gastrointestinal cancer. 2019. PMID: 30058032


Chloe Atreya, MD, PhD

Savoie MB, Paciorek A, Zhang L, Van Blarigan EL, Sommovilla N, Abrams D, Atreya CE, Bergsland EK, Chern H, Kelley RK, Ko A, Laffan A, Sarin A, Varma MG, Venook AP, Van Loon K. Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation. Journal of gastrointestinal cancer. 2019. PMID: 30058032


Emily Bergsland, MD